PRESS RELEASE published on 03/27/2025 at 18:00, 11 months 26 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 28.02.25. ABIVAX communique le nombre d'actions et de droits de vote au 28.02.25, conforme \ufffc les r\ufffeglementations financi\uffferes en vigueur. La soci\ufffet\ufff de biotechnologie est sp\ufffcialis\ufffe dans les traitements pour maladies inflammatoires chroniques Droits De Vote Biotechnologie Actions Abivax Traitements
BRIEF published on 03/26/2025 at 22:10, 11 months 27 days ago Abivax publie ses rapports financiers 2024 Biotechnologie AMF Abivax SEC Rapports Financiers
BRIEF published on 03/26/2025 at 22:10, 11 months 27 days ago Abivax publishes its 2024 financial reports Biotechnology AMF Abivax Financial Reports DRY
PRESS RELEASE published on 03/26/2025 at 22:05, 11 months 27 days ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax publie ses rapports financiers annuels pour l'année 2024 auprès des autorités de régulation des marchés financiers en France et aux États-Unis Autorité Des Marchés Financiers Biotechnologie Abivax Securities And Exchange Commission Rapports Financiers
PRESS RELEASE published on 03/26/2025 at 22:05, 11 months 27 days ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax Marchés Financiers Rapports Financiers Autorités Françaises Autorités Américaines
PRESS RELEASE published on 03/26/2025 at 22:05, 11 months 27 days ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes financial reports with French and U.S. securities regulatory agencies. The company filed its Universal Registration Document and Annual Report for 2024 Abivax Financial Reports Regulatory Agencies U.S. Securities French
BRIEF published on 03/24/2025 at 08:35, 11 months 29 days ago Abivax Publie ses Résultats Financiers pour 2024 Résultats Financiers Biotechnologie Recherche Et Développement Trésorerie Essais Cliniques
BRIEF published on 03/24/2025 at 08:35, 11 months 29 days ago Abivax Publishes its Financial Results for 2024 Financial Results Biotechnology Research And Development Treasury Clinical Trials
PRESS RELEASE published on 03/24/2025 at 08:30, 11 months 29 days ago Abivax Annonce ses Résultats Financiers pour l’Exercice 2024 Abivax annonce ses résultats financiers pour l’exercice 2024. Trésorerie de 144,2 millions d’euros au 31 décembre 2024. Perspectives financières disciplinées Résultats Financiers Biotechnologie Abivax Trésorerie Perspectives Financières
PRESS RELEASE published on 03/24/2025 at 08:30, 11 months 29 days ago Abivax Announces Full Year 2024 Financial Results Abivax announces full year 2024 financial results, cash balance of EUR 144.2M, ABTECT trial progress. CEO optimistic about 2025 milestones and financial outlook Financial Results Cash Position Abivax ABTECT Trial Clinical Progress
Published on 03/20/2026 at 13:30, 2 days 11 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 12 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 12 hours 15 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 1 hour ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 3 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days 3 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days 5 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 5 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 6 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 6 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
